Concepedia

Publication | Closed Access

Durability of Peginterferon Alfa-2B Treatment at 5 Years in Patients With Hepatitis B E Antigen–Positive Chronic Hepatitis B

DOI

116

Citations

33

References

2010

Year

Vincent Wai‐Sun Wong, Grace Lai–Hung Wong, Kenneth Yan, Angel Mei–Ling Chim, Hoi–Yun Chan, Chi‐Hang Tse, Paul Cheung‐Lung Choi, Anthony W.H. Chan, Joseph J.�Y. Sung, Henry Lik‐Yuen Chan
Hepatology

Abstract

Peginterferon has high durability in HBeAg-positive chronic hepatitis B patients with end-of-treatment virologic response.

References

YearCitations

Page 1